Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD.

Larsson TE, Kameoka C, Nakajo I, Taniuchi Y, Yoshida S, Akizawa T, Smulders RA.

Kidney Int Rep. 2017 Aug 12;3(1):73-80. doi: 10.1016/j.ekir.2017.08.003. eCollection 2018 Jan.

2.

The Pharmacokinetics of Beraprost Sodium Following Single Oral Administration to Subjects With Impaired Kidney Function.

Shimamura M, Miyakawa J, Doi M, Okada K, Kurumatani H, Mori Y, Oshida K, Nakajo I, Oikawa K, Ushigome F, Miyashita A, Isono M, Miyamoto Y.

J Clin Pharmacol. 2017 Apr;57(4):524-535. doi: 10.1002/jcph.835. Epub 2016 Nov 15.

PMID:
27681484
3.

Clinical pharmacokinetics and pharmacodynamics of the novel SGLT2 inhibitor ipragliflozin.

Kadokura T, Zhang W, Krauwinkel W, Leeflang S, Keirns J, Taniuchi Y, Nakajo I, Smulders R.

Clin Pharmacokinet. 2014 Nov;53(11):975-88. doi: 10.1007/s40262-014-0180-z. Review.

PMID:
25316572
4.

Urinary evaluation of the balance between soluble interferon-gamma receptor (IFN-gammaR1) and interleukin-4 receptor (IL-4Ralpha).

Okamoto Y, Nakajo I, Seta K, Gotoh Y, Nagai T, Fujita N, Fukui T, Masuzawa T.

Int Immunopharmacol. 2008 Dec 20;8(13-14):1859-62. doi: 10.1016/j.intimp.2008.09.001. Epub 2008 Sep 20.

PMID:
18809513
5.

Determination of age-related changes in human vascular endothelial growth factor in the serum and urine of healthy subjects.

Okamoto Y, Nagai T, Nakajo I, Seta K, Gotoh Y, Fujita N, Fukui T, Masuzawa T.

Clin Lab. 2008;54(5-6):173-7.

PMID:
18780663
6.

Age-dependent decrease in serum soluble interferon-gamma receptor (sIFN-gammaR) in healthy Japanese individuals; population study of serum sIFN-gammaR level in Japanese.

Okamoto Y, Seta K, Nakajo I, Gotoh Y, Nagai T, Fujita N, Fukui T, Masuzawa T.

J Immunoassay Immunochem. 2008;29(3):234-43. doi: 10.1080/15321810802122178.

PMID:
18569372
7.

[Examination of local alliances in clinical path (home parenteral nutrition)].

Ikedo H, Tanaka M, Matsumoto S, Nakajo I, Sugiyama H, Matsui W.

Gan To Kagaku Ryoho. 2006 Dec;33 Suppl 2:285-7. Japanese.

PMID:
17469362
8.

[Utilization of the screening test for discharge support].

Ikedo H, Morimoto R, Matsumoto S, Nakajo I, Nakagawa M.

Gan To Kagaku Ryoho. 2005 Dec;32 Suppl 1:47-9. Japanese.

PMID:
16422486
9.

Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor.

Kobayashi K, Yamanaka Y, Iwazaki N, Nakajo I, Hosokawa M, Negishi M, Chiba K.

Drug Metab Dispos. 2005 Jul;33(7):924-9. Epub 2005 Mar 31.

PMID:
15802384
10.

Hypercapnic and hypoxic ventilatory responses during growth.

Honda Y, Ohyabu Y, Sato M, Masuyama H, Nishibayashi Y, Maruyama R, Tanaka Y, Nakajo I, Shirase H, Hayashida K.

Jpn J Physiol. 1986;36(1):177-87.

PMID:
3088307

Supplemental Content

Loading ...
Support Center